5-[3,4-dihydroxy-5-(3,4,5-trihydroxyphenylcarbonyloxy)phenylcarbonyloxy]-3,4-dihydroxy-1-cyclohexene-1-carboxylic acid

ID: ALA39413

Chembl Id: CHEMBL39413

Cas Number: 95719-52-1

PubChem CID: 475266

Max Phase: Preclinical

Molecular Formula: C21H18O13

Molecular Weight: 478.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: 3-O-Digalloylshikimic Acid | 3-O-Digalloylshikimic acid|95719-52-1|CHEMBL39413|(3R,4R,5R)-5-({3,4-Dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoyl}oxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid|DTXSID70914842|BDBM50260543|(3R,4R,5R)-5-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxy-benzoyl]oxy-3,4-dihydroxy-cyclohexene-1-carboxylic acid|5-({3,4-Dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoyl}oxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid|Benzoic acid, 3,4(or 3,5)-dihydroxy-5(or 4)-[(3,4Show More

Canonical SMILES:  O=C(O)C1=C[C@@H](O)[C@@H](O)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)C1

Standard InChI:  InChI=1S/C21H18O13/c22-10-2-8(3-11(23)16(10)26)20(31)34-15-6-9(4-13(25)18(15)28)21(32)33-14-5-7(19(29)30)1-12(24)17(14)27/h1-4,6,12,14,17,22-28H,5H2,(H,29,30)/t12-,14-,17-/m1/s1

Standard InChI Key:  PKRKPJWPNZPNCK-SUYBPPKGSA-N

Alternative Forms

Associated Targets(Human)

PRKD3 Tchem Protein kinase C (PKC) (1010 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKD3 Tchem Protein kinase C, PKC; classical/novel (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TE-671 (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-8 (3484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pol Human immunodeficiency virus type 1 reverse transcriptase (18245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 478.36Molecular Weight (Monoisotopic): 478.0747AlogP: 0.10#Rotatable Bonds: 5
Polar Surface Area: 231.51Molecular Species: ACIDHBA: 12HBD: 8
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.04CX Basic pKa: CX LogP: 1.65CX LogD: -1.92
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.16Np Likeness Score: 1.41

References

1. Kilkuskie RE, Kashiwada Y, Nonaka G, Nishioka I, Bodner AJ, Cheng Y, Lee K.  (1992)  HIV and reverse transcriptase inhibition by tannins,  (12): [10.1016/S0960-894X(00)80422-9]
2. Kashiwada Y, Nonaka G, Nishioka I, Ballas LM, Jiang JB, Janzen WP, Lee K.  (1992)  Tannins as selective inhibitors of protein kinase C,  (3): [10.1016/S0960-894X(01)81072-6]
3. Kashiwada Y, Nonaka G, Nishioka I, Chang JJ, Lee KH..  (1992)  Antitumor agents, 129. Tannins and related compounds as selective cytotoxic agents.,  55  (8): [PMID:1431932] [10.1021/np50086a002]

Source